In May 2022, Precision BioLogic introduced its CRYOcheck Chromogenic Factor IX assay for monitoring hemophilia B in the EU, UK, Australia, Canada, and New Zealand after receiving regulatory approvals. This assay features a wide testing range, user-friendly design, and compatibility with automated analyzers, significantly improving hemophilia testing capabilities in these regions
